Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies
作者:Mónica Díaz-Gavilán、José A. Gómez-Vidal、Fernando Rodríguez-Serrano、Juan A. Marchal、Octavio Caba、Antonia Aránega、Miguel A. Gallo、Antonio Espinosa、Joaquín M. Campos
DOI:10.1016/j.bmcl.2007.12.070
日期:2008.2
Completing a SAR study, a series of (RS)-1- or 3-(1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and (RS)-6-substituted-7- or 9-(1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-7H- or 9H-purines have been prepared. Their antiproliferative activities on MCF-7 cells are here presented and discussed. (RS)-6-Chloro-9-[1-(9H-9-fluorenylmethoxycarbonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl]-9H-purine (28) is the most active (IC50 = 0.67 +/- 0.18 mu M) of the series so far described. cDNA microarray technology reveals potential drug targets, which are mainly centred on apoptosis regulatory pathway genes. (c) 2008 Elsevier Ltd. All rights reserved.